346 related articles for article (PubMed ID: 12455864)
41. Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
Golden-Mason L; Rosen HR
Liver Transpl; 2006 Mar; 12(3):363-72. PubMed ID: 16498647
[TBL] [Abstract][Full Text] [Related]
42. B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C.
Mochizuki K; Hayashi N; Katayama K; Hiramatsu N; Kanto T; Mita E; Tatsumi T; Kuzushita N; Kasahara A; Fusamoto H; Yokochi T; Kamada T
Hepatology; 1997 Mar; 25(3):713-8. PubMed ID: 9049224
[TBL] [Abstract][Full Text] [Related]
43. T-cell--mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection.
Liaw YF; Lee CS; Tsai SL; Liaw BW; Chen TC; Sheen IS; Chu CM
Hepatology; 1995 Nov; 22(5):1368-73. PubMed ID: 7590649
[TBL] [Abstract][Full Text] [Related]
44. Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis.
Autschbach F; Meuer SC; Moebius U; Manns M; Hess G; Meyer zum Büschenfelde KH; Thoenes W; Dienes HP
Hepatology; 1991 Aug; 14(2):223-30. PubMed ID: 1713565
[TBL] [Abstract][Full Text] [Related]
45. Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice.
Satoh K; Takahashi H; Matsuda C; Tanaka T; Miyasaka M; Zeniya M; Kohara M
J Med Virol; 2010 Sep; 82(9):1545-53. PubMed ID: 20648608
[TBL] [Abstract][Full Text] [Related]
46. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C.
Valiante NM; D'Andrea A; Crotta S; Lechner F; Klenerman P; Nuti S; Wack A; Abrignani S
Immunol Rev; 2000 Apr; 174():77-89. PubMed ID: 10807508
[TBL] [Abstract][Full Text] [Related]
47. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.
Durante-Mangoni E; Wang R; Shaulov A; He Q; Nasser I; Afdhal N; Koziel MJ; Exley MA
J Immunol; 2004 Aug; 173(3):2159-66. PubMed ID: 15265953
[TBL] [Abstract][Full Text] [Related]
48. Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver.
Exley MA; He Q; Cheng O; Wang RJ; Cheney CP; Balk SP; Koziel MJ
J Immunol; 2002 Feb; 168(4):1519-23. PubMed ID: 11823474
[TBL] [Abstract][Full Text] [Related]
49. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
50. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.
Cerny A; Chisari FV
Hepatology; 1999 Sep; 30(3):595-601. PubMed ID: 10462362
[TBL] [Abstract][Full Text] [Related]
51. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
52. Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells.
Ebihara T; Shingai M; Matsumoto M; Wakita T; Seya T
Hepatology; 2008 Jul; 48(1):48-58. PubMed ID: 18537195
[TBL] [Abstract][Full Text] [Related]
53. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity.
Khakoo SI; Soni PN; Savage K; Brown D; Dhillon AP; Poulter LW; Dusheiko GM
Am J Pathol; 1997 Mar; 150(3):963-70. PubMed ID: 9060834
[TBL] [Abstract][Full Text] [Related]
54. [The role of gamma-delta T-lymphocyte subtypes in normal and pathologic conditions].
Dosenko VIe; Goldenberg DI
Fiziol Zh (1994); 2001; 47(6):71-84. PubMed ID: 11962096
[TBL] [Abstract][Full Text] [Related]
55. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
Gonzalez VD; Landay AL; Sandberg JK
Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.
Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD
J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237
[TBL] [Abstract][Full Text] [Related]
57. Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells.
Cardona AE; Restrepo BI; Jaramillo JM; Teale JM
J Immunol; 1999 Jan; 162(2):995-1002. PubMed ID: 9916725
[TBL] [Abstract][Full Text] [Related]
58. Comparisons of peripheral blood and hepatic lymphocyte subpopulations and interferon production in chronic viral hepatitis.
Kakumu S; Yoshioka K; Wakita T; Ishikawa T; Murase K; Kusakabe A; Kurokawa S
J Clin Lab Immunol; 1990 Sep; 33(1):1-6. PubMed ID: 1726220
[TBL] [Abstract][Full Text] [Related]
59. Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase.
Watanabe H; Wells F; Major ME
J Viral Hepat; 2010 Apr; 17(4):245-53. PubMed ID: 19709361
[TBL] [Abstract][Full Text] [Related]
60. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
Moorman JP; Joo M; Hahn YS
Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
